Subject category:
Strategy and General Management
Published by:
Harvard Business Publishing
Version: 21 January 1994
Length: 20 pages
Data source: Field research
Share a link:
https://casecent.re/p/47162
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an early case in global strategy. The class can understand how Novo has competed internationally in the past, how that relates to industry structure, and how industry changes will alter the appropriate way of competing globally. Coalitions of alliances factor into the list of strategic alternatives.
Size:
$300 million sales
Other setting(s):
1982
About
Abstract
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an early case in global strategy. The class can understand how Novo has competed internationally in the past, how that relates to industry structure, and how industry changes will alter the appropriate way of competing globally. Coalitions of alliances factor into the list of strategic alternatives.
Settings
Size:
$300 million sales
Other setting(s):
1982